{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:01:12Z","timestamp":1790838072924,"version":"4.1.0"},"reference-count":30,"publisher":"Informa UK Limited","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2006,12,1]]},"DOI":"10.1185\/030079906x148355","type":"journal-article","created":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:37:46Z","timestamp":1162341466000},"page":"2419-2428","source":"Crossref","is-referenced-by-count":34,"title":["Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults"],"prefix":"10.1185","volume":"22","author":[{"given":"Philip A.","family":"Giordano","sequence":"first","affiliation":[{"name":"Orlando Regional Medical Center, Department of Emergency Medicine, Orlando, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Elston","sequence":"additional","affiliation":[{"name":"Geisinger Medical Center, Danville, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bolanle K.","family":"Akinlade","sequence":"additional","affiliation":[{"name":"Abbott Laboratories, North Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Weber","sequence":"additional","affiliation":[{"name":"Orlando Regional Medical Center, Department of Emergency Medicine, Orlando, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard F.","family":"Notario","sequence":"additional","affiliation":[{"name":"Abbott Laboratories, North Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd A.","family":"Busman","sequence":"additional","affiliation":[{"name":"Abbott Laboratories, North Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Cifaldi","sequence":"additional","affiliation":[{"name":"Abbott Laboratories, North Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"Nilius","sequence":"additional","affiliation":[{"name":"Abbott Laboratories, North Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2006,10,30]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/S0732-8893(98)00162-X"},{"key":"CIT0002","first-page":"p. 1037","author":"Swartz MN","year":"2000","journal-title":"Principles and practice of infectious diseases. New York: Churchill Livingstone Inc"},{"key":"CIT0003","unstructured":"US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. Uncomplicated and complicated skin and skin structure infections \u2013 developing antimicrobial drugs for treatment. Draft Guidance July 1998. At: http:\/\/www.fda.gov\/cder\/guidance\/index.htm [accessed: July 7, 2006]"},{"issue":"6","key":"CIT0004","first-page":"S15\u2013S19","volume":"4","author":"Elston DM","year":"2005","journal-title":"J Drugs Dermatol"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1086\/497143"},{"key":"CIT0006","unstructured":"NPA\u2122Plus (National Prescription Audit Plus). IMS Health. April, 2006"},{"key":"CIT0007","unstructured":"Physician Drug & Diagnosis Audit (PDDA) from Verispan, January 2006 \u2013 March 2006"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1007\/BF02111354"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1177\/106002809603000310"},{"key":"CIT0010","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1742-1241.1998.tb08892.x","volume":"52","author":"Wilson SE","year":"1998","journal-title":"Int J Clin Pract"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199345020-00008"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.4.739"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(02)80024-8"},{"key":"CIT0014","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1742-1241.2000.tb10911.x","volume":"54","author":"Parish LC","year":"2000","journal-title":"Int J Clin Pract"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(05)70112-2"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-5-200603070-00005"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.3201\/eid1106.040641"},{"key":"CIT0018","first-page":"707","volume":"48","author":"Centers for Disease Control and Prevention","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"CIT0019","first-page":"1128","volume":"29","author":"Lina G","year":"1999","journal-title":"Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis"},{"key":"CIT0020","unstructured":"Omnicef\u00aePrescribing Information. Abbott Laboratories \u00a92005. At: www.abbott.com [accessed July 7, 2006]"},{"key":"CIT0021","unstructured":"Keflex\u00aePrescribing Information. Advancis Pharmaceutical Corporation \u00a92005. At: http:\/\/www.advancispharm.com\/products\/keflex\/ [accessed July 7, 2006]"},{"key":"CIT0022","unstructured":"National Committee for Clinical Laboratory Standards, 2000. Performance standards for antimicrobial disk susceptibility tests; approved standard NCCLS document M2-A7 and 10th informational supplement (M100-S10[M2])"},{"key":"CIT0023","unstructured":"National Committee for Clinical Laboratory Standards, 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-fifth edition, M7-A5 and 10th informational supplement (M100 S10[M7])"},{"key":"CIT0024","first-page":"1169","volume":"25","author":"Matilde-Sanchez MM","year":"2006","journal-title":"X. Choosing the analysis population in non-inferiority studies: per-protocol or intent-to-treat. Statist Med"},{"key":"CIT0025","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; sixteenth informational supplement. CLSI document M100-S16 (ISBN 1\u201356238\u2013588\u20137). Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087\u20131898 USA, 2006"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000109288.06912.21"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.139.9.947"},{"key":"CIT0028","first-page":"1436","volume":"352","author":"Fridkin SK","year":"2005","journal-title":"for the Active Bacterial Core Surveillance Program of the Emerging Infections Program. Methicillin-resistant Staphylococcus aureus disease in three communities. New Engl J Med"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe058023"},{"key":"CIT0030","first-page":"199","volume":"20","author":"Madaras-Kelly KJ","year":"2000","journal-title":"Increased therapeutic failure for cephalexin versus comparator antibiotics in the treatment of uncomplicated outpatient cellulitis. Pharmaco-therapy"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/030079906X148355","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T23:07:08Z","timestamp":1707347228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1185\/030079906X148355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,30]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,12,1]]}},"alternative-id":["10.1185\/030079906X148355"],"URL":"https:\/\/doi.org\/10.1185\/030079906x148355","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,30]]}}}